Source link : https://newshealth.biz/health-news/nice-approves-sparsentan-for-kidney-disease-treatment/
The National Institute for Health and Care Excellence has recommended sparsentan (Filspari, Vifor Pharma) for treating primary immunoglobulin A nephropathy in adults. The recommendation reverses NICE’s February decision to reject NHS funding for the drug. The regulator had previously said available evidence did not demonstrate value for money. The manufacturer provided additional analyses and agreed to […]
The post NICE Approves Sparsentan for Kidney Disease Treatment first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-28 15:07:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8